Remarkably, this association is not limited to CKD patients (non-dialysis CKD (13, 14) and ESRD (15, 43)), but also detectable in patients without overt CKD (16–18, 44) in whom no primary significant FGF23 excess is to be expected. The gene discussed is FGF23; the disease is chronic kidney disease.